ApprovalTrail

Drug · DIN 02421186

TARO-TESTOSTERONE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since September 2, 2014; first marketed September 2, 2014.
Drug Identification Number (DIN)
02421186
Company (DIN owner)
Taro Pharmaceuticals IncBrampton, Ontario, Canada
Schedule
Controlled drugs (CDSA IV)
Dosage form
Capsule
Route
Oral
Therapeutic class (ATC)
Testosterone G03BA03
Class
Human
Record last updated
June 18, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
TESTOSTERONE UNDECANOATE40 MG

Notices of Compliance

Health Canada approvals that name this DIN.